Biomaterials Frontier event Sept. 10

3DHeals has scheduled its Biomaterials Frontier webinar for September 10, 2026, and is pitching it around a specific claim: the field is moving from “printing structure to printing function.” The event page says the discussion will focus on “standardized, regulator-legible material systems” across soft, hard and structural biomaterials used in 3D-printed medicine. 3DHeals says those tracks include function-first bioresins, ion-releasing ceramics and bioactive glass, and titanium or titanium-tantalum lattices. (3dheals.com) The September 10 program is being framed less as a broad futurist panel than as a materials-and-manufacturing discussion for people building medical products. 3DHeals says the session will bring together researchers, founders and industry leaders working on biomaterials as the “regulated, functional, investment-grade core” of 3D-printed medicine. Himed separately lists the same September 10 webinar on its events page. ### Why is 3DHeals centering the conversation on “function” instead of structure? 3DHeals says the “defining shift of 2026” is away from printing anatomy or geometry alone and toward materials that carry therapeutic, mechanical or biological performance requirements. (3dheals.com) The event description contrasts earlier attention on printable hydrogels or metal powders with a newer focus on biomaterials as the core of a regulated medical product. That framing matters because the materials named on the page map to different device problems. 3DHeals groups soft materials around bioresins, hard materials around bioactive ceramics and glass, and structural materials around titanium and titanium-tantalum lattices. (3dheals.com) The company’s wording suggests the discussion will treat material choice as part of device function, not just fabrication. ### Which speakers show where the event is aiming? Scott Taylor of Poly-Med is one of the named speakers on the 3DHeals page. 3DHeals identifies Taylor as Poly-Med’s director of product engineering and says he specializes in material selection and medical device design, with experience on development teams for more than 20 marketed medical devices. (3dheals.com) The same biography says Taylor has spent 10 years involved with ASTM committees F04 and F42, including chairing a joint group for absorbable polymeric materials and test methods. (3dheals.com) That places standards and test protocols alongside product design in the event’s speaker mix. Fabian Trumper of Arrakis Bio is also listed as a speaker. 3DHeals describes Arrakis Bio as working on “True Human Collagen” for regenerative medical and aesthetics applications and says Trumper has more than two decades of product, technology and business leadership experience. (3dheals.com) Johns Hopkins professor Kamal Choudhary is named as another speaker on the event page. ### Where does Himed fit into the picture? Himed’s own events listing says it will participate in the September 10 webinar and names Esther Valliant, a biomaterials research scientist at Himed, among the presenters. (3dheals.com) The company describes the session as a panel discussion on “the cutting edge of biomaterials technology.” Himed’s company materials help explain why it fits this lineup. Himed says it has supplied calcium phosphate powders, granules, abrasives and coatings to medical device manufacturers for 35 years, and 3DHeals material on related programming says the company has worked on bioceramic bioinks and biomaterial enhancements for implants. (3dheals.com) ### What does the event page suggest engineers will actually hear about? The 3DHeals description points to a practical set of issues: material selection, testing protocols, standards work, and how materials become “regulator-legible” systems. (himed.com) Taylor’s biography emphasizes physical and chemical testing, intellectual property, advanced manufacturing services and ASTM standards, all of which are closer to product development than to academic concept work. 3DHeals has been using similar language in recent posts. (himed.com) In an August 30 newsletter item, the company tied biomaterials risk to degradation profile, mechanical properties, immunogenicity and thrombogenicity in 3D-printed medical devices. ### What happens next? September 10, 2026, is the scheduled date on the 3DHeals event page, which includes registration and event email sign-up. Himed’s listing gives the time as 11:00 a.m. to 12:00 p.m. and identifies the session as an online webinar. (3dheals.com 1) (3dheals.com 2)